Find News

Filter articles

Showing 81 to 90 of 2614 results

Generic drugs cost 30x more in poor countries: report

India, US, Zimbabwe20-06-2019

Generic medicines can cost up to 30 times more in poor countries, according to a new study.

Amphastar enters into $59m settlement with Sandoz and Momenta


US pharmaceutical company Amphastar Pharmaceuticals is to receive $59.9 million in a settlement agreement with two of its competitors, Sandoz and Momenta Pharmaceuticals.

US officials call for review of government-owned IP management


A US congressman and senator have asked the country’s audit institution, the Government Accountability Office to review the management of government-owned IP in the health sector.

Pharma companies join forces to block list price disclosure


Pharmaceutical companies Merck & Co, Eli Lilly, and Amgen are suing the US Department of Health and Human Services over proposed rules which would force companies to disclose the list prices of drugs in TV advertisements.

English High Court upholds Sequenom patent for prenatal test


US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.

Pfizer to acquire Array BioPharma for $11.4bn


US biopharmaceutical company Pfizer has entered agreed to acquire Array BioPharma, a biotechnology company which develops small molecule drugs for the treatment of cancer.

FDA selects Merck, IBM, KPMG and Walmart for blockchain pilot


The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.

GSK unites with CRISPR pioneer Doudna

UK, US14-06-2019

British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.

Dassault Systèmes makes $5.8bn health data deal

US13-06-2019Mergers & acquisitions

Software company Dassault Systèmes has targeted the life sciences sector with the $5.8 billion acquisition of Medidata Solutions, a US-firm firm focused on clinical trials.

BASF appeals to Federal Circuit in agritech dispute


BASF Plant Science, the plant biotech-focused subsidiary of BASF, has asked the US Court of Appeals for the Federal Circuit to overturn a finding that certain claims of a transgenic plant technology patent were invalid.

Showing 81 to 90 of 2614 results